Valeant Pharmaceuticals International Chief Pearson Explores Acquisitions for Expansion Outside U.S.

Bloomberg -- Valeant Pharmaceuticals International Inc. has a $500 million budget for acquisitions and is seeking opportunities to expand outside the U.S., Chief Executive Officer Michael Pearson said.